Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

3 Top Healthcare Stocks to Buy in May: https://g.foolcdn.com/editorial/images/730742/scientists-high-five-smile.jpg
3 Top Healthcare Stocks to Buy in May

Healthcare stocks always make a great addition to long-term portfolios. They offer you the potential to benefit from steady earnings growth over time. After all, regardless of the economic

3 Top Healthcare Stocks to Buy in May: https://g.foolcdn.com/editorial/images/730742/scientists-high-five-smile.jpg
3 Top Healthcare Stocks to Buy in May

Healthcare stocks always make a great addition to long-term portfolios. They offer you the potential to benefit from steady earnings growth over time. After all, regardless of the economic

Why Amgen Stock Was Sickly Today: https://g.foolcdn.com/editorial/images/730881/two-people-seated-at-a-lab-desk-featuring-a-pc-screen-and-microscope.jpg
Why Amgen Stock Was Sickly Today

Investors are often encouraged when one of their companies bulks up by acquiring a peer. But that sentiment can turn sour if the takeover target stumbles.

This was the impetus behind Amgen's

Why Amgen Stock Was Sickly Today: https://g.foolcdn.com/editorial/images/730881/two-people-seated-at-a-lab-desk-featuring-a-pc-screen-and-microscope.jpg
Why Amgen Stock Was Sickly Today

Investors are often encouraged when one of their companies bulks up by acquiring a peer. But that sentiment can turn sour if the takeover target stumbles.

This was the impetus behind Amgen's

Why Amgen Stock Was Sickly Today: https://g.foolcdn.com/editorial/images/730881/two-people-seated-at-a-lab-desk-featuring-a-pc-screen-and-microscope.jpg
Why Amgen Stock Was Sickly Today

Investors are often encouraged when one of their companies bulks up by acquiring a peer. But that sentiment can turn sour if the takeover target stumbles.

This was the impetus behind Amgen's

EQS-News: MorphoSys AG Reports First Quarter 2023 Financial Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys AG Reports First Quarter 2023 Financial Results
EQS-News: MorphoSys AG Reports First Quarter 2023 Financial Results
EQS-News: MorphoSys AG Reports First Quarter 2023 Financial Results: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
EQS-News: MorphoSys AG Reports First Quarter 2023 Financial Results
EQS-News: MorphoSys AG Reports First Quarter 2023 Financial Results
Amarin Plc (AMRN) Q1 2023 Earnings Call Transcript: https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg
Amarin Plc (AMRN) Q1 2023 Earnings Call Transcript

Image source: The Motley Fool.

Amarin Plc (NASDAQ: AMRN)Q1 2023 Earnings CallMay 03, 2023, 8:00 a.m. ET

Operator

Continue reading

Source Fool.com

2 Things About AbbVie That Investors Are Ignoring: https://g.foolcdn.com/editorial/images/730557/gettyimages-1318178022.jpg
2 Things About AbbVie That Investors Are Ignoring

Investors were ready for declines in AbbVie's (NYSE: ABBV) blockbuster immunology drug Humira. The product now is facing competition in the U.S. So, seeing a 26% drop in Humira's U.S. first-quarter

Why Eli Lilly Stock Is Bolting Higher Today: https://g.foolcdn.com/editorial/images/730771/alzheimers.jpg
Why Eli Lilly Stock Is Bolting Higher Today

Shares of the Illinois-based drugmaker Eli Lilly (NYSE: LLY) were up by 6% on heavy volume as of 1:45 p.m. ET Wednesday.

What sparked this latest rally? Ahead of the opening bell, Lilly announced

Why Eli Lilly Stock Is Bolting Higher Today: https://g.foolcdn.com/editorial/images/730771/alzheimers.jpg
Why Eli Lilly Stock Is Bolting Higher Today

Shares of the Illinois-based drugmaker Eli Lilly (NYSE: LLY) were up by 6% on heavy volume as of 1:45 p.m. ET Wednesday.

What sparked this latest rally? Ahead of the opening bell, Lilly announced

Why Eli Lilly Stock Is Bolting Higher Today: https://g.foolcdn.com/editorial/images/730771/alzheimers.jpg
Why Eli Lilly Stock Is Bolting Higher Today

Shares of the Illinois-based drugmaker Eli Lilly (NYSE: LLY) were up by 6% on heavy volume as of 1:45 p.m. ET Wednesday.

What sparked this latest rally? Ahead of the opening bell, Lilly announced

Why ImmunoGen Stock Is Soaring Wednesday: https://g.foolcdn.com/editorial/images/730764/clovisnew.jpg
Why ImmunoGen Stock Is Soaring Wednesday

Shares of ImmunoGen (NASDAQ: IMGN) were up by 139% Wednesday morning after the company announced positive trial data concerning an ovarian cancer drug the company has in its pipeline. The biotech

Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc: https://mms.businesswire.com/media/20210505005534/en/876086/5/5009664_Horizon_Logo_Full-Color_CMYK_M01_%281%29.jpg
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Is This Incredibly Cheap, High-Yield Dividend Stock a Screaming Buy After Q1 Earnings?: https://g.foolcdn.com/editorial/images/730524/high-yield.jpg
Is This Incredibly Cheap, High-Yield Dividend Stock a Screaming Buy After Q1 Earnings?

High-quality dividend stocks are normally a great addition to any portfolio regardless of market conditions. However, this exceedingly risk-averse market has punished even elite dividend-paying

Is This Incredibly Cheap, High-Yield Dividend Stock a Screaming Buy After Q1 Earnings?: https://g.foolcdn.com/editorial/images/730524/high-yield.jpg
Is This Incredibly Cheap, High-Yield Dividend Stock a Screaming Buy After Q1 Earnings?

High-quality dividend stocks are normally a great addition to any portfolio regardless of market conditions. However, this exceedingly risk-averse market has punished even elite dividend-paying

Here's 1 Magnificent Reason to Buy Vertex Pharmaceuticals Stock: https://g.foolcdn.com/editorial/images/730213/physician-shaking-patients-hand.jpg
Here's 1 Magnificent Reason to Buy Vertex Pharmaceuticals Stock

Had you bought Vertex Pharmaceuticals (NASDAQ: VRTX) shares 10 years ago, you'd be sitting pretty right now. The drugmaker soundly outperformed the market over that period thanks to its success in

Here's 1 Magnificent Reason to Buy Vertex Pharmaceuticals Stock: https://g.foolcdn.com/editorial/images/730213/physician-shaking-patients-hand.jpg
Here's 1 Magnificent Reason to Buy Vertex Pharmaceuticals Stock

Had you bought Vertex Pharmaceuticals (NASDAQ: VRTX) shares 10 years ago, you'd be sitting pretty right now. The drugmaker soundly outperformed the market over that period thanks to its success in

Here's 1 Magnificent Reason to Buy Vertex Pharmaceuticals Stock: https://g.foolcdn.com/editorial/images/730213/physician-shaking-patients-hand.jpg
Here's 1 Magnificent Reason to Buy Vertex Pharmaceuticals Stock

Had you bought Vertex Pharmaceuticals (NASDAQ: VRTX) shares 10 years ago, you'd be sitting pretty right now. The drugmaker soundly outperformed the market over that period thanks to its success in

3 of the Best Growth Stocks to Buy in May: https://g.foolcdn.com/editorial/images/730234/a-couple-smiling-and-talking-with-an-advisor.jpg
3 of the Best Growth Stocks to Buy in May

The bull market hasn't arrived yet, but when it does, growth stocks could be hot buys again. Three growing businesses stand out to me as good buys for investors to consider right now: UnitedHealth

3 of the Best Growth Stocks to Buy in May: https://g.foolcdn.com/editorial/images/730234/a-couple-smiling-and-talking-with-an-advisor.jpg
3 of the Best Growth Stocks to Buy in May

The bull market hasn't arrived yet, but when it does, growth stocks could be hot buys again. Three growing businesses stand out to me as good buys for investors to consider right now: UnitedHealth

Good News for Patients Is Lifting These 2 Biopharma Stocks: https://g.foolcdn.com/editorial/images/730733/biotech-scientist-microscope-getty.jpg
Good News for Patients Is Lifting These 2 Biopharma Stocks

Overall, the stock market is facing a serious case of the jitters on Wednesday morning, as investors wait anxiously for the coming decision on interest rates from the Federal Reserve later this

University of North Florida and Humana Expand Meals on Wings Program to Address Food Insecurity Among Older Adults: https://mms.businesswire.com/media/20230419005329/en/1767750/5/MOW_%28003%29.jpg
University of North Florida and Humana Expand Meals on Wings Program to Address Food Insecurity Among Older Adults


The University of North Florida (UNF) and Humana Inc., a leading health and well-being company, have collaborated to expand the University’s Meals on Wings program into two new communities to help

Dexcom G6 Real-Time CGM System Now Accessible to Any Eligible Client Managing Diabetes With Insulin Through NIHB: https://mms.businesswire.com/media/20230427005246/en/1776192/5/GG1_0630_%281%29.jpg
Dexcom G6 Real-Time CGM System Now Accessible to Any Eligible Client Managing Diabetes With Insulin Through NIHB


Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, applauds the progressive expansion of coverage for continuous glucose

Dexcom G6 Real-Time CGM System Now Accessible to Any Eligible Client Managing Diabetes With Insulin Through NIHB: https://mms.businesswire.com/media/20230427005246/en/1776192/5/GG1_0630_%281%29.jpg
Dexcom G6 Real-Time CGM System Now Accessible to Any Eligible Client Managing Diabetes With Insulin Through NIHB


Dexcom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (rtCGM) for people with diabetes, applauds the progressive expansion of coverage for continuous glucose